Variants of Transient Receptor Potential Melastatin Member 4 in Childhood Atrioventricular Block
Authors:
- Stéphanie ChatelSCStéphanie Chatel
- Lijo Cherian OzhathilLOLijo Cherian Ozhathil
- Jean‐Sébastien RougierJRJean‐Sébastien Rougier
- Alban BaruteauABAlban Baruteau
- Mohamed‐Yassine AmarouchMAMohamed‐Yassine Amarouch
- Vincent ProbstVPVincent Probst
- Jean‐Jacques SchottJSJean‐Jacques Schott
- Hugues AbrielHAHugues Abriel
Open Access
- 6 May 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 5 (5)
Abstract
Background: Transient receptor potential melastatin member 4 ( TRPM 4) is a nonselective cation channel. TRPM 4 mutations have been linked to cardiac conduction disease and Brugada syndrome. The mechanisms underlying TRPM 4‐dependent conduction slowing are not fully understood. The aim of this study was to characterize TRPM 4 genetic variants found in patients with congenital or childhood atrioventricular block. Methods and Results: Ninety‐one patients with congenital or childhood atrioventricular block were screened for candidate genes. Five rare TRPM 4 genetic variants were identified and investigated. The variants were expressed heterologously in HEK 293 cells. Two of the variants, A432T and A432T/G582S, showed decreased expression of the protein at the cell membrane; inversely, the G582S variant showed increased expression. Further functional characterization of these variants using whole‐cell patch‐clamp configuration showed a loss of function and a gain of function, respectively. We hypothesized that the observed decrease in expression was caused by a folding and trafficking defect. This was supported by the observation that incubation of these variants at lower temperature partially rescued their expression and function. Previous studies have suggested that altered SUMO ylation of TRPM 4 may cause a gain of function; however, we did not find any evidence that supports SUMO ylation as being directly involved for the gain‐of‐function variant. Conclusions: This study underpins the role of TRPM 4 in the cardiac conduction system. The loss‐of‐function variants A432T/G582S found in 2 unrelated patients with atrioventricular block are most likely caused by misfolding‐dependent altered trafficking. The ability to rescue this variant with lower temperature may provide a novel use of pharmacological chaperones in treatment strategies.Keywords
This publication has 37 references indexed in Scilit:
- Identification of PDZ Domain Containing Proteins Interacting with 1.2 and PMCA4bISRN Cell Biology, 2013
- Molecular Genetics and Functional Anomalies in a Series of 248 Brugada Cases with 11 Mutations in the TRPM4 ChannelPLOS ONE, 2013
- Neuronal Precursor Cell-expressed Developmentally Down-regulated 4-1 (NEDD4-1) Controls the Sorting of Newly Synthesized CaV1.2 Calcium ChannelsJournal of Biological Chemistry, 2011
- Pharmacological inhibition of TRPM4 hyperpolarizes vascular smooth muscleAmerican Journal of Physiology-Cell Physiology, 2010
- Molecular mechanisms of microvascular failure in central nervous system injury—synergistic roles of NKCC1 and SUR1/TRPM4Journal of Neurosurgery, 2010
- Gain-of-Function Mutations in TRPM4 Cause Autosomal Dominant Isolated Cardiac Conduction DiseaseCirculation: Cardiovascular Genetics, 2010
- Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type IJournal of Clinical Investigation, 2009
- Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humansJournal of Clinical Investigation, 2008
- Brugada syndrome and fever: Genetic and molecular characterization of patients carrying mutationsCardiovascular Research, 2005
- Observations on the mechanism of one type of so-called supernormal A-V conductionAmerican Heart Journal, 1971